CONMED CORPORATION Inventory, Finished Goods, Net of Reserves
CONMED CORPORATION (CNMD) had Inventory, Finished Goods, Net of Reserves of $204.95 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-07-29
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $204.95M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $212.65M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $227.78M.
- 2025-06-30: Inventory, Finished Goods, Net of Reserves $218.83M.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $204.95M 10-Q · filed 2026-07-29 | |
| 2025-12-31 | $212.65M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $227.78M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $218.83M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $207.76M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $200.69M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $203.95M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $188.11M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $188.27M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $181.60M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $179.90M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $175.56M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $184.76M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $195.48M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $166.41M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $158.53M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $141.53M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $130.81M 10-K · filed 2023-02-21 | |
| 2021-09-30 | $134.28M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $121.41M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $113.71M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $107.20M 10-K · filed 2022-02-22 | |
| 2020-09-30 | $101.12M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $100.78M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $105.47M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $98.37M 10-K · filed 2021-02-22 | |
| 2019-09-30 | $103.52M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $105.77M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $103.25M 10-Q · filed 2019-04-26 | |
| 2018-12-31 | $93.70M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $94.31M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $85.73M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $88.39M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $84.93M 10-K · filed 2019-02-25 | |
| 2017-09-30 | $90.98M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $81.72M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $75.62M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $79.73M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $127.96M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $120.22M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $119.36M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $71.76M 10-K · filed 2017-02-27 | $105.29M 10-K · filed 2016-02-23 |
| 2015-09-30 | $98.57M 10-Q · filed 2015-10-23 | |
| 2015-06-30 | $89.22M 10-Q · filed 2015-07-27 | |
| 2015-03-31 | $85.69M 10-Q · filed 2015-04-24 | |
| 2014-12-31 | $89.43M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $98.68M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $94.05M 10-Q · filed 2014-07-25 | |
| 2014-03-31 | $92.11M 10-Q · filed 2014-04-25 | |
| 2013-12-31 | $89.45M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $93.10M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $88.58M 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $96.31M 10-Q · filed 2013-04-29 | |
| 2012-12-31 | $96.88M 10-K · filed 2014-02-24 | |
| 2012-09-30 | $104.32M 10-Q · filed 2012-10-29 | |
| 2012-06-30 | $96.58M 10-Q · filed 2012-07-30 | |
| 2012-03-31 | $98.59M 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $100.59M 10-K · filed 2013-02-25 | |
| 2010-12-31 | $108.30M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |